NEXT SUPER STOCK: Nova Mentis Life Sciences (OTC: NMLSF) (CSE: NOVA) CMO Marvin Hausman, M.D.: “Nova’s Psilocybin-based Therapeutics Showing Vast Potential for Autism and Other Neuroinflammatory Disorders” Update on  4/8/2022 livestream discussing clinical trial application … Continue reading NEXT SUPER STOCK: Nova Mentis Life Sciences (OTC: NMLSF) Billions Opportunity w/ autism psilocybin